Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pautas

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
La Revue De Medecine Interne|March 10, 2001
[Monitoring of tinzaparin in a ten day treatment dose in elderly patients]E Pautas, V Siguret, M d'Urso, et al.
Annales De Biologie Clinique|March 30, 2004
[Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients]G Dewulf, I Gouin, E Pautas, et al.
Annales De Biologie Clinique|May 16, 2006
[Prescribing guidance pocket chart on the initiation of warfarin therapy in a geriatric hospital: a useful but challenging tool]V Siguret, A N'Guyen, M Harboun, et al.
Clinical and Experimental Rheumatology|May 17, 2000
Features of polymyositis and dermatomyositis in the elderly: a case-control studyE Pautas, P Chérin, J C Piette, et al.
The Journal of Nutrition, Health & Aging|July 10, 2010
Scurvy in hospitalized elderly patientsA Raynaud-Simon, J Cohen-Bittan, A Gouronnec, et al.
Annales De Biologie Clinique|December 16, 1998
[Macrophage activation in a 74-year-old man]F Niel, E Pautas, A Beauchef, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2011
Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypesC Moreau, E Pautas, I Gouin-Thibault, et al.
Thrombosis and Haemostasis|December 29, 2000
Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 daysV Siguret, E Pautas, M Février, et al.
The Journal of Hospital Infection|September 21, 2010
Decolonisation for early control of an outbreak of vancomycin-resistant Enterococcus faecium in a geriatric rehabilitation care facilityF Brossier, S Lefrançois, J Paute, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatientsE Pautas, C Moreau, I Gouin-Thibault, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
La Revue De Medecine Interne|March 10, 2001
[Monitoring of tinzaparin in a ten day treatment dose in elderly patients]E Pautas, V Siguret, M d'Urso, et al.
Annales De Biologie Clinique|March 30, 2004
[Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients]G Dewulf, I Gouin, E Pautas, et al.
Annales De Biologie Clinique|May 16, 2006
[Prescribing guidance pocket chart on the initiation of warfarin therapy in a geriatric hospital: a useful but challenging tool]V Siguret, A N'Guyen, M Harboun, et al.
Clinical and Experimental Rheumatology|May 17, 2000
Features of polymyositis and dermatomyositis in the elderly: a case-control studyE Pautas, P Chérin, J C Piette, et al.
The Journal of Nutrition, Health & Aging|July 10, 2010
Scurvy in hospitalized elderly patientsA Raynaud-Simon, J Cohen-Bittan, A Gouronnec, et al.
Annales De Biologie Clinique|December 16, 1998
[Macrophage activation in a 74-year-old man]F Niel, E Pautas, A Beauchef, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2011
Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypesC Moreau, E Pautas, I Gouin-Thibault, et al.
Thrombosis and Haemostasis|December 29, 2000
Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 daysV Siguret, E Pautas, M Février, et al.
The Journal of Hospital Infection|September 21, 2010
Decolonisation for early control of an outbreak of vancomycin-resistant Enterococcus faecium in a geriatric rehabilitation care facilityF Brossier, S Lefrançois, J Paute, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatientsE Pautas, C Moreau, I Gouin-Thibault, et al.
Pageof 4